Gilead Sciences Canada receives approval notice for Vosevi in refractory HCV Aug. 18, 2017 No Comments
Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease May 30, 2017 No Comments
VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada June 27, 2016 No Comments
RSS